APA (7th ed.) Citation

Awasthi, M., Macaluso, A., Myscofski, D., Prigge, J., Koide, F., Noyce, R. S., . . . Lederman, S. (2023). Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, against SARS-CoV-2 Challenge in Nonhuman Primates. Vaccines (Basel), 11(11), 1682. https://doi.org/10.3390/vaccines11111682

Chicago Style (17th ed.) Citation

Awasthi, Mayanka, et al. "Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, Against SARS-CoV-2 Challenge in Nonhuman Primates." Vaccines (Basel) 11, no. 11 (2023): 1682. https://doi.org/10.3390/vaccines11111682.

MLA (9th ed.) Citation

Awasthi, Mayanka, et al. "Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, Against SARS-CoV-2 Challenge in Nonhuman Primates." Vaccines (Basel), vol. 11, no. 11, 2023, p. 1682, https://doi.org/10.3390/vaccines11111682.